Any current/future new fundraising through debt or equity?

There is no explicit mention of any current or planned fundraising through debt or equity in the transcript. Shishir Joshipura noted that capital allocation decisions are a Board matter and did not disclose any specifics about dividend, buyback, or fresh fundraising plans. Customers may need to seek bank loans or financial institution funding depending on their capital allocation policies for adding multi-feed solutions or building alternative feedstock capacity, but this is on the customer side, not Praj Industries itself. Praj intends to make prudent investments, especially in new tech

Any current/future capex/capital investment/strategic investment?

Praj is investing significantly in R&D with planned CAPEX of ₹30-40 crores and revenue expenditure (OPEX) of ₹30-40 crores for the next year, totaling ₹70-80 crores in R&D investment. Capital allocation will focus on capacity building and capability development to support renewable chemicals and materials sectors. The PLA (polylactic acid) demo plant is nearing completion, expected to start operations by April 2024, marking an investment in indigenous bioplastics technology. GenX facility at Mangalore is progressing with all statutory approvals completed, aiming for commercial production by mi

Future growth expectations in sales/revenue/volumes?

Praj expects 3X growth in revenue by FY30, reaffirming confidence in this target. The renewable chemicals and materials landscape is projected to expand significantly in the mid to long term, driving capital allocation toward capacity building. Increasing demand in bioenergy, sustainable aviation fuel (SAF), compressed biogas (CBG), and bioplastics is expected to propel growth. International markets, especially with rising SAF production capacities in the US and India, are seen as growth drivers. Expansion in service business and higher export orders are anticipated to improve sales mix and ma

Future growth expectations in earnings/operating earnings/profits/EPS?

Praj Industries expects to achieve 3X revenue growth by FY30, with confidence in meeting or beating this target (Page 14). Strong momentum in bioenergy, bio-manufacturing, renewable chemicals, and materials sectors indicates positive growth trajectories (Pages 14-15). Margins are expected to improve gradually due to product mix changes, higher international sales, increased services orders, and softer material costs; double-digit PAT margins are anticipated over time (Pages 15-16). R&D investment of Rs. 70-80 crores planned for next year to drive innovation and new products, enhancing future r

Current/ Expected Orderbook/ Pending Orders?

As of September 2023, the order backlog stood at Rs. 39.5 billion (Rs. 3950 crores), with 75% domestic orders. Bio-energy segment accounts for about Rs. 3000 crores of this backlog. Out of the bio-energy backlog, roughly Rs. 250 crores pertains to syrup-based plants (slow-moving), and Rs. 450 crores involves B-Heavy plants with mixed feedstock. The quarterly order intake was Rs. 10.3 billion, with 86% from the domestic market. 81% of the quarterly order intake came from bio-energy, 12% from engineering, and 7% from PHS business. There is a temporary shift in execution cycles due to reassessmen

Praj IndustriesQ3 FY24Industrial Manufacturing

Praj Industries Q3 FY24 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹300P/E: 110.3Market Cap: ₹5.6K CrSector: Industrial Manufacturing

Management growth scorecard

Revenue

Category 2

Margin

Category 3

Fundraise

N/A

Order

Capex

Yes

1 of 4 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 2

Praj expects 3X growth in revenue by FY30, reaffirming confidence in this target.
The renewable chemicals and materials landscape is projected to expand significantly in the mid to long term, driving capital allocation toward capacity building.
Increasing demand in bioenergy, sustainable aviation fuel (SAF), compressed biogas (CBG), and bioplastics is expected to propel growth.
International markets, especially with rising SAF production capacities in the US and India, are seen as growth drivers.
Expansion in service business and higher export orders are anticipated to improve sales mix and margins.
The domestic bioenergy business is positive, with innovations addressing feedstock challenges expected to restore and grow order intake.
New product segments like PLA and continuous R&D investment (~Rs. 70-80 crores next year) aim to bring blockbuster products, contributing significantly to future revenues.
The company's order pipeline is healthy and expanding, bolstered by government policies supporting bio-manufacturing and energy transition.

Margin guidance

Category 3

Praj Industries expects to achieve 3X revenue growth by FY30, with confidence in meeting or beating this target (Page 14).
Strong momentum in bioenergy, bio-manufacturing, renewable chemicals, and materials sectors indicates positive growth trajectories (Pages 14-15).
Margins are expected to improve gradually due to product mix changes, higher international sales, increased services orders, and softer material costs; double-digit PAT margins are anticipated over time (Pages 15-16).
R&D investment of Rs. 70-80 crores planned for next year to drive innovation and new products, enhancing future revenue streams (Page 16).
Healthy order pipeline, including new segments like CBG and Sustainable Aviation Fuel (SAF), supports optimistic earnings outlook (Pages 6-7, 9-10).
Margins and profitability will benefit from increased exports and services business growth (Page 10).
Some short-term project execution delays expected due to policy adjustments, but overall long-term outlook remains positive (Pages 6-7, 12).

See what Praj Industries management said on margin guidance — free account, 30 seconds.

Fundraise plans

There is no explicit mention of any current or planned fundraising through debt or equity in the transcript.
Shishir Joshipura noted that capital allocation decisions are a Board matter and did not disclose any specifics about dividend, buyback, or fresh fundraising plans.
Customers may need to seek bank loans or financial institution funding depending on their capital allocation policies for adding multi-feed solutions or building alternative feedstock capacity, but this is on the customer side, not Praj Industries itself.
Praj intends to make prudent investments, especially in new technologies and capacity building, but specifics about raising new funds have not been disclosed.
The company has Rs. 6.4 billion cash in hand as of September 30, 2023, which may support ongoing investments without immediate fundraising needs.

Order book

As of September 2023, the order backlog stood at Rs. 39.5 billion (Rs. 3950 crores), with 75% domestic orders.
Bio-energy segment accounts for about Rs. 3000 crores of this backlog.
Out of the bio-energy backlog, roughly Rs. 250 crores pertains to syrup-based plants (slow-moving), and Rs. 450 crores involves B-Heavy plants with mixed feedstock.
The quarterly order intake was Rs. 10.3 billion, with 86% from the domestic market.
81% of the quarterly order intake came from bio-energy, 12% from engineering, and 7% from PHS business.
There is a temporary shift in execution cycles due to reassessment of feedstock supply influences but no cancellations.
New growth areas include multiple feedstock solutions and increasing orders from international markets in energy transition sectors.

See what Praj Industries management said on order book — free account, 30 seconds.

Capex plans

Yes

Praj is investing significantly in R&D with planned CAPEX of ₹30-40 crores and revenue expenditure (OPEX) of ₹30-40 crores for the next year, totaling ₹70-80 crores in R&D investment.
Capital allocation will focus on capacity building and capability development to support renewable chemicals and materials sectors.
The PLA (polylactic acid) demo plant is nearing completion, expected to start operations by April 2024, marking an investment in indigenous bioplastics technology.
GenX facility at Mangalore is progressing with all statutory approvals completed, aiming for commercial production by mid-February.
Expansion in multi-feedstock ethanol plant solutions involves possible capital requirements depending on customer decisions, sometimes requiring external funding or internal cash allocation.
The company remains open to prudently investing in new growth areas aligned with energy transition and sustainability agenda.

Track Praj Industries — get its next earnings analysis in your feed

How does Praj Industries rank vs peers in Industrial Manufacturing?

Pro feature

ThisPraj Industries

Rev 2Mar 3

See where Praj Industries sits in Industrial ManufacturingSee which companies these are, and every other name in the sector.Open rankings

How does Praj Industries rank in Industrial Manufacturing?

Compare Praj Industries against every Industrial Manufacturing company (Q3 FY24) on revenue, margins and earnings-call signals.

View Industrial Manufacturing leaderboard →

What Praj Industries's management said in earlier quarters

Others in Industrial Manufacturing this season

TRF Ltd (Q1 FY27)
Revenue figures reported for FY2024, FY2025, and FY2026 are ₹160 Cr, ₹135 Cr, and ₹100 Cr respectively, showing a year-on-year decline. Key investor presentatio
Adisoft Technologies Ltd (Q1 FY27)
H2 FY26 Income:** ₹119.7 Cr vs ₹81.7 Cr in H2 FY25 . Key investor presentation takeaways from Adisoft Technologies Ltd's Q1 FY27 investor presentation — and how
Concord Control Systems Ltd (Q1 FY25)
22.45 Cr orders during April to June 2024 on a consolidated basis (Page 8). Key concall takeaways from Concord Control Systems Ltd's Q1 FY25 earnings call…
Honeywell Automation India Ltd (Q1 FY21)
Q1 Apr–Jun 2020 Revenue (Total Income from Operations): INR 736.2 Crores . Key concall takeaways from Honeywell Automation India Ltd's Q1 FY21 earnings call…

Compare:vs Indo-MIM Ltd vs Aditya Infotech vs Cochin Shipyard

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →